Skip to main content
OpenTrials
Completed

NCT Number: NCT01988545

GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Køge Hospital

Køge, State..., 4600, Denmark

About this study

to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy subjects

Exclusion criteria

  • medical conditions

Treatment and study plan

1,5 nmol/kg,GLP-1 sc injection

Other

Other names: native GLP-1

1,5 nmol/kg GLP-1 9-36amide, sc injection

Other

Exendin-4 ;10 ug,sc injection

Other

Saline

Other

Primary outcomes

  1. blood flow

    Time frame: with in 120 minutes

    blood flow change measured by ultra sound

Other outcomes

  1. cardiac parameters

    Time frame: with in 120 minutes

    measure of cardiac change with task force monitor

Sponsors and collaborators

Lead sponsor

Zealand University Hospital

Other

Collaborators

  • Glostrup University Hospital, Copenhagen
  • University of Copenhagen

Registry information

Official study title

GLP-1's Influence on Intestinal Blood Flow

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Nov 20, 2013
Registry last updated
Sep 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.